Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DND1P1 is a human pseudogene with high sequence similarity to the microRNA-mediated repression inhibitor DND1[1][4]. Pseudogenes such as DND1P1 do not encode functional proteins but may play biological roles as RNA molecules, including acting as ceRNAs that interact with microRNAs and mRNAs in regulatory networks[2][3]. Pseudogenes may have tissue-specific or disease-related expression patterns and affect gene regulation through antisense, RNA interference, or miRNA decoy mechanisms[2][3]. However, DND1P1 itself is not a direct therapeutic target and does not have recognized interacting drugs, clinical biomarkers, or disease associations at present[4].
Not applicable; no drugs target DND1P1 directly[4]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DND microRNA-mediated repression inhibitor 1 pseudogene 1 (DND1P1).